SCHEMBL10156537

SCHEMBL10156537

CCN(CC)C(=O)c1cc(N)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.43
FEN1 P39748 1/20 0.43
HSP90AA1 P07900 5/20 0.42
HSP90AB1 P08238 5/20 0.42
PARP1 P09874 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MAPT P10636 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TSHR P16473 1/20 0.39
HPGD P15428 2/20 0.39
MLYCD O95822 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP1A2 P05177 1/20 0.39
BLM P54132 1/20 0.39
OPRM1 P35372 2/20 0.39
OPRD1 P41143 2/20 0.39
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KEAP1 Q14145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13666711 0.87 ALOX5AP (0.43) ALOX5APFEN1HSP90AA1HSP90AB1ALDH1A1
SCHEMBL7218207 0.83 CES2 (0.55) HSP90AA1HSP90AB1ALDH1A1MAPTL3MBTL1
SCHEMBL12677875 0.81 HPGD (0.51) HSP90AA1HSP90AB1PARP1ALDH1A1MAPT
SCHEMBL17774878 0.81 HSP90AA1 (0.62) HSP90AA1HSP90AB1ALDH1A1MAPTL3MBTL1
SCHEMBL7225379 0.81 HPGD (0.49) HSP90AA1HSP90AB1ALDH1A1MAPTTSHR
SCHEMBL5906549 0.81 AR (0.47) ALDH1A1MAPTHPGDTDP1BLM
SCHEMBL16942492 0.80 HSP90AA1 (0.47) HSP90AA1HSP90AB1ALDH1A1MAPTL3MBTL1
SCHEMBL11112425 0.79 HSP90AA1 (0.44) HSP90AA1HSP90AB1ALDH1A1MAPTHPGD
SCHEMBL17774813 0.79 MAPT (0.44) HSP90AA1HSP90AB1ALDH1A1MAPTTSHR
SCHEMBL13958999 0.78 TP53 (0.46) ALOX5APFEN1HSP90AA1HSP90AB1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487491-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2016-11-08 US disclosed
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-12-18 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 ALOX5AP 3807/4885FEN1 4302/4885HSP90AA1 4617/4885
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 ALOX5AP 3807/4885FEN1 4302/4885HSP90AA1 4617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.